ID   MBOA1_HUMAN             Reviewed;         495 AA.
AC   Q6ZNC8; A9EDQ5; B4DL59; B4E3J4; Q86XC2; Q8N9R5;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 108.
DE   RecName: Full=Lysophospholipid acyltransferase 1;
DE            Short=LPLAT 1;
DE            EC=2.3.1.-;
DE   AltName: Full=1-acylglycerophosphoserine O-acyltransferase;
DE            EC=2.3.1.n6;
DE   AltName: Full=Lysophosphatidylserine acyltransferase;
DE            Short=LPSAT;
DE            Short=Lyso-PS acyltransferase;
DE   AltName: Full=Membrane-bound O-acyltransferase domain-containing protein 1;
DE            Short=O-acyltransferase domain-containing protein 1;
GN   Name=MBOAT1; Synonyms=OACT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=17890783; DOI=10.1074/jbc.M704509200;
RA   Tamaki H., Shimada A., Itoh Y., Ohya M., Takase J., Miyashita M.,
RA   Miyagawa H., Nozaki H., Nakayama R., Kumagai H.;
RT   "LPT1 encodes a membrane-bound O-acyltransferase involved in the
RT   acylation of lysophospholipids in the yeast Saccharomyces
RT   cerevisiae.";
RL   J. Biol. Chem. 282:34288-34298(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Tongue, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=18772128; DOI=10.1074/jbc.M806194200;
RA   Gijon M.A., Riekhof W.R., Zarini S., Murphy R.C., Voelker D.R.;
RT   "Lysophospholipid acyltransferases and arachidonate recycling in human
RT   neutrophils.";
RL   J. Biol. Chem. 283:30235-30245(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-488, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Acyltransferase which mediates the conversion of
CC       lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-
CC       serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3-
CC       phospho-L-serine or PS) (LPSAT activity). Prefers oleoyl-CoA as
CC       the acyl donor. Lysophospholipid acyltransferases (LPLATs)
CC       catalyze the reacylation step of the phospholipid remodeling
CC       pathway also known as the Lands cycle.
CC       {ECO:0000269|PubMed:18772128}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-
CC       phosphatidylserine = CoA + 1,2-diacyl-sn-glycero-3-
CC       phosphatidylserine.
CC   -!- ENZYME REGULATION: Partially inhibited by thimerosal.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZNC8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZNC8-2; Sequence=VSP_036729;
CC       Name=3;
CC         IsoId=Q6ZNC8-3; Sequence=VSP_036730, VSP_036731;
CC   -!- TISSUE SPECIFICITY: Expressed in neutrophils.
CC       {ECO:0000269|PubMed:18772128}.
CC   -!- SIMILARITY: Belongs to the membrane-bound acyltransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB305043; BAF93899.1; -; mRNA.
DR   EMBL; AK093994; BAC04264.1; -; mRNA.
DR   EMBL; AK131269; BAD18447.1; -; mRNA.
DR   EMBL; AK296857; BAG59421.1; -; mRNA.
DR   EMBL; AK304748; BAG65506.1; -; mRNA.
DR   EMBL; AL158198; CAH71585.1; -; Genomic_DNA.
DR   EMBL; AL008627; CAH71585.1; JOINED; Genomic_DNA.
DR   EMBL; AL355139; CAH71585.1; JOINED; Genomic_DNA.
DR   EMBL; AL008627; CAI19512.1; -; Genomic_DNA.
DR   EMBL; AL158198; CAI19512.1; JOINED; Genomic_DNA.
DR   EMBL; AL355139; CAI19512.1; JOINED; Genomic_DNA.
DR   EMBL; AL355139; CAI20913.1; -; Genomic_DNA.
DR   EMBL; AL008627; CAI20913.1; JOINED; Genomic_DNA.
DR   EMBL; AL158198; CAI20913.1; JOINED; Genomic_DNA.
DR   EMBL; BC150650; AAI50651.1; -; mRNA.
DR   EMBL; BC150652; AAI50653.1; -; mRNA.
DR   CCDS; CCDS34346.1; -. [Q6ZNC8-1]
DR   RefSeq; NP_001073949.1; NM_001080480.2. [Q6ZNC8-1]
DR   RefSeq; XP_011512615.1; XM_011514313.2. [Q6ZNC8-3]
DR   UniGene; Hs.377830; -.
DR   ProteinModelPortal; Q6ZNC8; -.
DR   BioGrid; 127537; 31.
DR   IntAct; Q6ZNC8; 31.
DR   STRING; 9606.ENSP00000324944; -.
DR   SwissLipids; SLP:000000133; -.
DR   iPTMnet; Q6ZNC8; -.
DR   PhosphoSitePlus; Q6ZNC8; -.
DR   DMDM; 74749574; -.
DR   EPD; Q6ZNC8; -.
DR   MaxQB; Q6ZNC8; -.
DR   PaxDb; Q6ZNC8; -.
DR   PeptideAtlas; Q6ZNC8; -.
DR   PRIDE; Q6ZNC8; -.
DR   DNASU; 154141; -.
DR   Ensembl; ENST00000324607; ENSP00000324944; ENSG00000172197. [Q6ZNC8-1]
DR   GeneID; 154141; -.
DR   KEGG; hsa:154141; -.
DR   UCSC; uc003ncx.4; human. [Q6ZNC8-1]
DR   CTD; 154141; -.
DR   DisGeNET; 154141; -.
DR   GeneCards; MBOAT1; -.
DR   HGNC; HGNC:21579; MBOAT1.
DR   HPA; HPA052996; -.
DR   MIM; 611732; gene.
DR   neXtProt; NX_Q6ZNC8; -.
DR   OpenTargets; ENSG00000172197; -.
DR   PharmGKB; PA134979205; -.
DR   eggNOG; KOG2704; Eukaryota.
DR   eggNOG; COG5202; LUCA.
DR   GeneTree; ENSGT00550000074565; -.
DR   HOGENOM; HOG000015994; -.
DR   HOVERGEN; HBG058823; -.
DR   InParanoid; Q6ZNC8; -.
DR   KO; K13517; -.
DR   OMA; FVHKASF; -.
DR   OrthoDB; EOG091G06A8; -.
DR   PhylomeDB; Q6ZNC8; -.
DR   TreeFam; TF314906; -.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   UniPathway; UPA00085; -.
DR   ChiTaRS; MBOAT1; human.
DR   GenomeRNAi; 154141; -.
DR   PRO; PR:Q6ZNC8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000172197; -.
DR   CleanEx; HS_MBOAT1; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0047144; F:2-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR004299; MBOAT_fam.
DR   Pfam; PF03062; MBOAT; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Complete proteome;
KW   Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    495       Lysophospholipid acyltransferase 1.
FT                                /FTId=PRO_0000273018.
FT   TRANSMEM     34     54       Helical. {ECO:0000255}.
FT   TRANSMEM     70     90       Helical. {ECO:0000255}.
FT   TRANSMEM    126    146       Helical. {ECO:0000255}.
FT   TRANSMEM    180    200       Helical. {ECO:0000255}.
FT   TRANSMEM    238    258       Helical. {ECO:0000255}.
FT   TRANSMEM    297    317       Helical. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   TRANSMEM    450    470       Helical. {ECO:0000255}.
FT   ACT_SITE    350    350       {ECO:0000250}.
FT   ACT_SITE    381    381       {ECO:0000250}.
FT   MOD_RES     488    488       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    158       MAAEPQPSSLSYRTTGSTYLHPLSELLGIPLDQVNFVVCQL
FT                                VALFAAFWFRIYLRPGTTSSDVRHAVATIFGIYFVIFCFGW
FT                                YSVHLFVLVLMCYAIMVTASVSNIHRYSFFVAMGYLTICHI
FT                                SRIYIFHYGILTTDFSGPLMIVTQKITTLAFQVHD -> ME
FT                                FSLRIFL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036729.
FT   VAR_SEQ     240    241       AV -> HL (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036730.
FT   VAR_SEQ     242    495       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036731.
FT   VARIANT     450    450       I -> V (in dbSNP:rs2065649).
FT                                /FTId=VAR_050025.
FT   CONFLICT    170    170       E -> G (in Ref. 2; BAG59421).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       S -> P (in Ref. 2; BAG59421).
FT                                {ECO:0000305}.
FT   CONFLICT    438    438       V -> I (in Ref. 2; BAC04264).
FT                                {ECO:0000305}.
SQ   SEQUENCE   495 AA;  56557 MW;  8666D7068D46FCD5 CRC64;
     MAAEPQPSSL SYRTTGSTYL HPLSELLGIP LDQVNFVVCQ LVALFAAFWF RIYLRPGTTS
     SDVRHAVATI FGIYFVIFCF GWYSVHLFVL VLMCYAIMVT ASVSNIHRYS FFVAMGYLTI
     CHISRIYIFH YGILTTDFSG PLMIVTQKIT TLAFQVHDGL GRRAEDLSAE QHRLAIKVKP
     SFLEYLSYLL NFMSVIAGPC NNFKDYIAFI EGKHIHMKLL EVNWKRKGFH SLPEPSPTGA
     VIHKLGITLV SLLLFLTLTK TFPVTCLVDD WFVHKASFPA RLCYLYVVMQ ASKPKYYFAW
     TLADAVNNAA GFGFSGVDKN GNFCWDLLSN LNIWKIETAT SFKMYLENWN IQTATWLKCV
     CYQRVPWYPT VLTFILSALW HGVYPGYYFT FLTGILVTLA ARAVRNNYRH YFLSSRALKA
     VYDAGTWAVT QLAVSYTVAP FVMLAVEPTI SLYKSMYFYL HIISLLIILF LPMKPQAHTQ
     RRPQTLNSIN KRKTD
//
